These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28926510)

  • 1. Restoring vaginal function in postmenopausal women with genitourinary syndrome of menopause.
    Kagan R; Rivera E
    Menopause; 2018 Jan; 25(1):106-108. PubMed ID: 28926510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Call to Change the Narrative on Genitourinary Syndrome of Menopause.
    Rudd AB; Davis A
    Nurs Womens Health; 2020 Dec; 24(6):399-403. PubMed ID: 33157068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of genitourinary syndrome of menopause in female cancer patients: a focus on vaginal hormonal therapy.
    Crean-Tate KK; Faubion SS; Pederson HJ; Vencill JA; Batur P
    Am J Obstet Gynecol; 2020 Feb; 222(2):103-113. PubMed ID: 31473229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genitourinary Syndrome of Menopause: Management Strategies for the Clinician.
    Faubion SS; Sood R; Kapoor E
    Mayo Clin Proc; 2017 Dec; 92(12):1842-1849. PubMed ID: 29202940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New therapeutic option in genitourinary syndrome of menopause: pilot study using microablative fractional radiofrequency.
    Kamilos MF; Borrelli CL
    Einstein (Sao Paulo); 2017; 15(4):445-451. PubMed ID: 29364367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause.
    Gambacciani M; Levancini M; Russo E; Vacca L; Simoncini T; Cervigni M
    Climacteric; 2018 Apr; 21(2):148-152. PubMed ID: 29436235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management.
    Gandhi J; Chen A; Dagur G; Suh Y; Smith N; Cali B; Khan SA
    Am J Obstet Gynecol; 2016 Dec; 215(6):704-711. PubMed ID: 27472999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexual Function in Women Suffering From Genitourinary Syndrome of Menopause Treated With Fractionated CO
    Salvatore S; Pitsouni E; Del Deo F; Parma M; Athanasiou S; Candiani M
    Sex Med Rev; 2017 Oct; 5(4):486-494. PubMed ID: 28843942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating Menopausal Symptoms.
    Am Fam Physician; 2016 Dec; 94(11):Online. PubMed ID: 27929272
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of vaginal therapies alternative to vaginal estrogens on sexual function and orgasm of menopausal women: A systematic review and meta-analysis of randomized controlled trials.
    Pitsouni E; Grigoriadis T; Douskos A; Kyriakidou M; Falagas ME; Athanasiou S
    Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():45-56. PubMed ID: 30103082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term effect of vaginal erbium laser on the genitourinary syndrome of menopause.
    Gambacciani M; Levancini M
    Minerva Ginecol; 2015 Apr; 67(2):97-102. PubMed ID: 25763800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety.
    Vicariotto F; DE Seta F; Faoro V; Raichi M
    Minerva Ginecol; 2017 Aug; 69(4):342-349. PubMed ID: 28608667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device.
    Vicariotto F; Raichi M
    Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CO
    Athanasiou S; Pitsouni E; Falagas ME; Salvatore S; Grigoriadis T
    Maturitas; 2017 Oct; 104():24-28. PubMed ID: 28923173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition?
    Edwards D; Panay N
    Climacteric; 2016 Apr; 19(2):151-61. PubMed ID: 26707589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-hormonal treatments for menopausal symptoms.
    Hickey M; Szabo RA; Hunter MS
    BMJ; 2017 Nov; 359():j5101. PubMed ID: 29170264
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of oestriol gel on dyspareunia in postmenopausal women in 2 weeks of treatment: a pilot study.
    Cuerva MJ; González SP; Lazaro-Carrasco De La Fuente J; Lopez FJ; Nieto C
    J Obstet Gynaecol; 2022 Oct; 42(7):3397-3399. PubMed ID: 35658728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The urogenital system and the menopause.
    Calleja-Agius J; Brincat MP
    Climacteric; 2015; 18 Suppl 1():18-22. PubMed ID: 26366796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laser therapy for the restoration of vaginal function.
    Gambacciani M; Palacios S
    Maturitas; 2017 May; 99():10-15. PubMed ID: 28364861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vulvar and vaginal fractional CO2 laser treatments for genitourinary syndrome of menopause.
    Streicher LF
    Menopause; 2018 May; 25(5):571-573. PubMed ID: 29406425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.